Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: August 11, 2022

Prednisolone - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What are the generic drug sources for prednisolone and what is the scope of freedom to operate?

Prednisolone is the generic ingredient in thirty-eight branded drugs marketed by Schering, Akorn, Chartwell Rx, Ivax Sub Teva Pharms, Lannett Co Inc, Nesher Pharms, Pharm Assoc, Teva Pharms, We Pharms, Wockhardt Bio Ag, Muro, Teva, Halsey, Pharmacia And Upjohn, Ferndale Labs, Barr, Bundy, Elkins Sinn, Everylife, Ferrante, Fosun Pharma, Heather, Impax Labs, Inwood Labs, Lannett, Marshall Pharma, Panray, Phoenix Labs Ny, Purepac Pharm, Pvt Form, Rising, Roxane, Sperti, Superpharm, Tablicaps, UDL, Valeant Pharm Intl, Vitarine, Watson Labs, West Ward, Whiteworth Town Plsn, Pfizer, Bel Mar, Cent Pharms, Eyevance, Novartis, Allergan, Taro, Alcon, Pharmafair, Bausch And Lomb, Merck, Alcon Pharms Ltd, Sola Barnes Hind, Concordia Pharms Inc, Seton Pharm, Amneal Pharms, Bausch, Edenbridge Pharms, Mission Pharma, Vintage, Vintage Pharms, Mylan Pharms Inc, and Sandoz Inc, and is included in one hundred and twenty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighty-eight drug master file entries for prednisolone. Eight suppliers are listed for this compound.

Drug Prices for prednisolone

See drug prices for prednisolone

Drug Sales Revenue Trends for prednisolone

See drug sales revenues for prednisolone

Recent Clinical Trials for prednisolone

Identify potential brand extensions & 505(b)(2) entrants

Eurofarma Laboratorios S.A.Phase 3
University of OuluPhase 4
Sparrow PharmaceuticalsPhase 2

See all prednisolone clinical trials

Pharmacology for prednisolone
Medical Subject Heading (MeSH) Categories for prednisolone

US Patents and Regulatory Information for prednisolone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc PREDNISOLONE prednisolone SYRUP;ORAL 040775-001 Sep 21, 2007 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Akorn PREDNISOLONE ACETATE prednisolone acetate INJECTABLE;INJECTION 084492-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Vitarine PREDNISOLONE prednisolone TABLET;ORAL 080534-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

EU/EMA Drug Approvals for prednisolone

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
LE VET B.V. Equisolon Prednisolone EMEA/V/C/002382
Alleviation of inflammatory and clinical parameters associated with recurrent airway obstruction (RAO) in horses, in combination with environmental control.
Authorised no no no 2014-03-12
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.